|
TURQUOISE-III: SAFETY AND EFFICACY OF 12-WEEK RIBAVIRIN-FREE
TREATMENT FOR PATIENTS WITH HCV GENOTYPE 1B AND CIRRHOSIS
|
|
|
Reported by Jules Levin
15th International Symposium on Viral Hepatitis and Liver Disease, Berlin, Germany, 26 June 2015
Jordan J Feld, Christophe Moreno, Roger Trinh, Edward Tam, Stefan Bourgeois, Yves Horsmans, Magdy Elkhashab, David E Bernstein, Ziad Younes, Bo Fu, Andreas Pangerl, Nancy S Shulman, Fred Poordad
![HCV1.gif](../images/062915/062615-3/HCV1.gif)
![HCV2.gif](../images/062915/062615-3/HCV2.gif)
![HCV3.gif](../images/062915/062615-3/HCV3.gif)
![HCV4.gif](../images/062915/062615-3/HCV4.gif)
![HCV5.gif](../images/062915/062615-3/HCV5.gif)
![HCV6.gif](../images/062915/062615-3/HCV6.gif)
![HCV7.gif](../images/062915/062615-3/HCV7.gif)
![HCV8.gif](../images/062915/062615-3/HCV8.gif)
![HCV9.gif](../images/062915/062615-3/HCV9.gif)
|
|
|
|
|
|
|